Quantum BioPharma (STU:0K91) Cyclically Adjusted FCF per Share: €-44.87 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0K91 Quantum BioPharma Ltd STU:0K91
20 GF Score
Price €2.44
! 5 Warning Signs
View Full Analysis

What is Quantum BioPharma Cyclically Adjusted FCF per Share?

Quantum BioPharma STU:0K91 -4.53% 20 Cyclically Adjusted FCF per Share is €-44.87 as of Mar. 2026. GuruFocus rates STU:0K91 with a GF Score™ of 20/100. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Quantum BioPharma's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.322. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-44.87 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-05), Quantum BioPharma's current stock price is €2.442. Quantum BioPharma's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-44.87. Quantum BioPharma's Cyclically Adjusted Price-to-FCF of today is .


Quantum BioPharma  (STU:0K91) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Quantum BioPharma Cyclically Adjusted FCF per Share Related Terms


Quantum BioPharma Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Quantum BioPharma's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum BioPharma Cyclically Adjusted FCF per Share Chart

Quantum BioPharma Annual Data
Trend Aug16 Aug17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -50.92

Quantum BioPharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -50.92 -44.87

STU:0K91 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Quantum BioPharma's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum BioPharma Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum BioPharma's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Quantum BioPharma's Cyclically Adjusted Price-to-FCF falls into.


STU:0K91
20GF Score
Quantum BioPharma Ltd STU:0K91
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quantum BioPharma Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Quantum BioPharma's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.322/132.2623*132.2623
=-0.322

Current CPI (Mar. 2026) = 132.2623.

Quantum BioPharma Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201605 0.000 101.765 0.000
201608 -0.020 101.686 -0.026
201611 -0.020 101.607 -0.026
201702 -0.089 102.476 -0.115
201705 -0.050 103.108 -0.064
201708 -0.030 103.108 -0.038
201711 -0.030 103.740 -0.038
201802 -0.386 104.688 -0.488
201806 -23.732 105.557 -29.736
201809 -58.627 105.636 -73.404
201812 -22.491 105.399 -28.223
201903 -25.047 106.979 -30.967
201906 -46.370 107.690 -56.950
201909 -16.466 107.611 -20.238
201912 -25.529 107.769 -31.331
202003 -39.776 107.927 -48.745
202006 -23.777 108.401 -29.011
202009 -22.390 108.164 -27.378
202012 -13.295 108.559 -16.198
202103 -12.143 110.298 -14.561
202106 -9.865 111.720 -11.679
202109 -7.061 112.905 -8.272
202112 -5.745 113.774 -6.679
202203 -7.911 117.646 -8.894
202206 -15.027 120.806 -16.452
202209 -13.077 120.648 -14.336
202212 -10.134 120.964 -11.081
202303 -7.412 122.702 -7.989
202306 -5.363 124.203 -5.711
202309 -2.662 125.230 -2.811
202312 -1.289 125.072 -1.363
202403 -2.975 126.258 -3.116
202406 -0.878 127.522 -0.911
202409 -3.397 127.285 -3.530
202412 -0.347 127.364 -0.360
202503 -1.592 129.181 -1.630
202506 -0.559 129.892 -0.569
202509 -0.386 130.287 -0.392
202512 -0.068 130.366 -0.069
202603 -0.322 132.262 -0.322

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-44.87 mean?
Quantum BioPharma (STU:0K91) has a Cyclically Adjusted FCF per Share of €-44.87 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Quantum BioPharma and its competitors.
Is Quantum BioPharma's Cyclically Adjusted FCF per Share too high?
Quantum BioPharma's current Cyclically Adjusted FCF per Share is €-44.87. Overall, Quantum BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Quantum BioPharma's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Quantum BioPharma's Cyclically Adjusted FCF per Share of €-44.87 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Quantum BioPharma and its competitors. Quantum BioPharma's current Cyclically Adjusted FCF per Share is €-44.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum BioPharma stock overvalued right now?
Quantum BioPharma (STU:0K91) has a current Cyclically Adjusted FCF per Share of €-44.87. The current Cyclically Adjusted FCF per Share is €-44.87. Quantum BioPharma's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Quantum BioPharma (STU:0K91), the current Cyclically Adjusted FCF per Share is €-44.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quantum BioPharma Business Description

Other Exchanges QNTM:USAQNTM:Canada
Address 1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
20GF Score

Get the complete analysis for STU:0K91

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.44
Price